Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$25.10 – $31.90
10% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $653.2M | $585.8M | $69.04B | $65.38B | $67.49B | $75.58B | $88.33B | $98.02B |
| Cost of revenue | $249.8M | $271.6M | $345.3M | $298.7M | $284.5M | $38.24B | $44.27B | $51.91B |
| Gross profit | $403.5M | $314.2M | $279.5M | $238.4M | $223.6M | $37.34B | $44.06B | $46.11B |
| Gross margin | 61.8% | 53.6% | 0.4% | 0.4% | 0.3% | 49.4% | 49.9% | 47.0% |
| R&D | $141.9M | $99.7M | $9.63B | $10.36B | $10.39B | $0 | $0 | $0 |
| Operating income | $56.1M | $17.2M | $1.50B | −$1.40B | −$1.13B | $4.02B | $5.77B | −$2.94B |
| EBITDA | $9.75B | $40.9M | $4.65B | $2.33B | $2.97B | $18.72B | $20.25B | $1.73B |
| Net income | $49.5M | $26.1M | $5.29B | $12.92B | $10.53B | $11.16B | $11.96B | $13.87B |
| Net margin | 7.6% | 4.5% | 7.7% | 19.8% | 15.6% | 14.8% | 13.5% | 14.1% |
| EPS (diluted) | 1.06 | 0.56 | 113.25 | 280.20 | 228.31 | 246.58 | 274.21 | 333.94 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $91.9B | $267.12 | $226.20–$294.38 | 1 |
| 2028 | $97.4B | $290.15 | $245.71–$319.76 | 1 |
| 2029 | $101.4B | $308.16 | $260.96–$339.61 | 1 |
| 2030 | $105.4B | $338.39 | $286.56–$372.93 | 1 |
Forward consensus · source: Financial Modeling Prep
KISSEI PHARM CO LTD
No one on the platform currently holds KSPHF.
No tracked institution reports a position in KSPHF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $65.0000 | |
| 2026-09-30 | $65.0000 | |
| 2026-09-30 | $40.0000 | |
| 2026-03-31 | $40.0000 | 2026-06-24 |
| 2026-03-31 | $60.0000 | 2026-06-24 |
| 2025-09-30 | $60.0000 | 2025-12-02 |
| 2025-03-31 | $55.0000 | 2025-06-25 |
| 2024-09-30 | $45.0000 | 2024-12-03 |
| 2024-03-28 | $41.0000 | 2024-06-26 |
| 2023-09-29 | $41.0000 | 2023-12-04 |
No one on the platform has traded KSPHF yet.
| +0.00% |
| $1.2B |
| — |
| LJUIFSSY Group Limited | $0.40 | +0.00% | $1.2B | — |
| NPPNYNippon Shinyaku Co., Ltd. | $6.00 | +0.00% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.1× historical median P/E.
Fair value ≈ $23.51 · price $25.77 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.